BSW Wealth Partners Has $501,000 Stake in The Cigna Group (NYSE:CI)

BSW Wealth Partners reduced its stake in shares of The Cigna Group (NYSE:CI) by 2.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,446 shares of the health services provider’s stock after selling 39 shares during the quarter. BSW Wealth Partners’ holdings in The Cigna Group were worth $501,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Angeles Wealth Management LLC increased its stake in shares of The Cigna Group by 30.2% in the 3rd quarter. Angeles Wealth Management LLC now owns 1,418 shares of the health services provider’s stock valued at $491,000 after buying an additional 329 shares during the period. Van ECK Associates Corp increased its position in The Cigna Group by 1.8% in the third quarter. Van ECK Associates Corp now owns 15,137 shares of the health services provider’s stock worth $4,807,000 after purchasing an additional 265 shares during the period. Harbor Capital Advisors Inc. bought a new stake in The Cigna Group during the 3rd quarter worth about $45,000. Janney Montgomery Scott LLC raised its holdings in The Cigna Group by 4.5% during the 3rd quarter. Janney Montgomery Scott LLC now owns 31,664 shares of the health services provider’s stock worth $10,970,000 after purchasing an additional 1,372 shares during the last quarter. Finally, Pure Financial Advisors LLC raised its stake in shares of The Cigna Group by 6.3% during the third quarter. Pure Financial Advisors LLC now owns 898 shares of the health services provider’s stock worth $311,000 after buying an additional 53 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Insiders Place Their Bets

In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the business’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $342.68, for a total value of $922,151.88. Following the completion of the sale, the director now owns 17,539 shares of the company’s stock, valued at $6,010,264.52. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.60% of the company’s stock.

The Cigna Group Stock Performance

Shares of CI stock opened at $316.49 on Monday. The stock has a market cap of $88.47 billion, a P/E ratio of 29.86, a P/E/G ratio of 0.95 and a beta of 0.51. The company has a fifty day moving average price of $345.77 and a two-hundred day moving average price of $341.48. The Cigna Group has a one year low of $253.95 and a one year high of $370.83. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.71.

The Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The business had revenue of $63.70 billion during the quarter, compared to analysts’ expectations of $59.58 billion. During the same quarter last year, the company posted $6.77 earnings per share. The Cigna Group’s quarterly revenue was up 29.8% on a year-over-year basis. As a group, equities analysts predict that The Cigna Group will post 28.48 EPS for the current year.

The Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Wednesday, December 4th will be paid a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date of this dividend is Wednesday, December 4th. The Cigna Group’s dividend payout ratio is presently 52.83%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on CI shares. StockNews.com raised The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 2nd. Stephens restated an “overweight” rating and set a $410.00 price objective on shares of The Cigna Group in a report on Friday. JPMorgan Chase & Co. increased their target price on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a report on Wednesday, August 21st. Royal Bank of Canada decreased their price target on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a report on Friday. Finally, Barclays raised their price objective on The Cigna Group from $393.00 to $405.00 and gave the stock an “overweight” rating in a research note on Friday, August 2nd. One analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, The Cigna Group has an average rating of “Buy” and a consensus target price of $392.29.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.